Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium
Stefan Blankenberg(Universität Hamburg), Kari Kuulasmaa(Finnish Institute for Health and Welfare), Barbara Thorand(Helmholtz Zentrum München), Astrid Petersmann(Carl von Ossietzky Universität Oldenburg), Philipp S. Wild(Johannes Gutenberg University Mainz), Simona Costanzo(Istituto Neurologico Mediterraneo), Brendan M. Everett(Cedars-Sinai Medical Center), Wolfgang Köenig(German Centre for Cardiovascular Research), Licia Iacoviello(Istituto Neurologico Mediterraneo), Gerard J. Linden(Queen's University Belfast), Matthias Nauck(Universität Greifswald), Frank Kee(Queen's University Belfast), Tanja Zeller(Universität Hamburg), Nataliya Makarova(German Centre for Cardiovascular Research), Francisco Ojeda(Universidad Complutense de Madrid), Erkki Vartiainen(Unknown), Veikko Salomaa(Finnish Institute for Health and Welfare), Karl J. Lackner(Johannes Gutenberg University Mainz), Annette Peters(Zimmer Biomet (Netherlands)), Renate B. Schnabel(Universität Hamburg), Giovanni Veronesi(University of Insubria), Paul M. Ridker(Herlev Hospital), Paolo Brambilla(Azienda Ospedaliera San Gerardo), John Yarnell(Queen's University Belfast), Torben Jørgensen(University of Copenhagen), Christopher Patterson(University of Wollongong), Jukka Kontto(Finnish Institute for Health and Welfare)
Site cant be reached
October 7, 2016
Cited by 0
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Richness of human gut microbiome correlates with metabolic markers
|Nature|2013|4.7k
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
|New England Journal of Medicine|2002|3.6k
A reference panel of 64,976 haplotypes for genotype imputation
|Nature Genetics|2016|3.3k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k